Stockscreener 앱 받기
4.615
1.12%
0.045
Opus Genetics Inc 주식(IRD)의 최신 뉴스
FDA reviewing NC biotech's treatment for age-related vision loss - The Business Journals
Where Opus Genetics Stands With Analysts - Sahm
Opus Genetics to Present at Upcoming Investor Conferences in March 2026 - The Manila Times
Opus Genetics (NASDAQ:IRD) Price Target Raised to $12.00 - MarketBeat
FY2026 EPS Estimates for Opus Genetics Raised by Analyst - MarketBeat
Opus Genetics, Inc. (NASDAQ:IRD) Short Interest Update - MarketBeat
Opus Genetics (NASDAQ:IRD) Upgraded by Wall Street Zen to Hold Rating - MarketBeat
Opus Genetics reports early positive data from gene therapy trial - Investing.com South Africa
Opus Genetics (IRD) Shares Promising Gene Therapy Results - GuruFocus
Opus Genetics reports early positive data from gene therapy trial By Investing.com - Investing.com Canada
Opus Genetics Announces Initial Clinical Data from Phase - GlobeNewswire
IRD Should I Buy - Intellectia AI
Opus Genetics earnings beat, revenue fell short of estimates By Investing.com - Investing.com Canada
FDA accepts Opus Genetics’ presbyopia treatment application By Investing.com - Investing.com Australia
FDA accepts sNDA of phentolamine 0.75% for presbyopia - Eyes On Eyecare
FDA accepts Opus Genetics’ presbyopia treatment application - Investing.com Nigeria
Viatris, Opus Genetics Say US FDA Agrees to Review New Drug Application for Potential Eye Condition Treatment - marketscreener.com
Viatris, Opus gain as FDA to review label expansion for eyecare drug - Seeking Alpha
FDA Reviews Opus Genetics' (IRD) New Eye Treatment for Presbyopi - GuruFocus
Opus Genetics Announces FDA Acceptance Of Supplemental New Drug Application For Phentolamine Ophthalmic Solution 0.75% For The Treatment Of Presbyopia - TradingView
Eye drops for aging eyes: FDA reviews Opus presbyopia treatment - Stock Titan
Chipmakers Recap: Can Opus Genetics Inc weather a recessionProduct Launch & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Opus Genetics: Asymmetric Upside With LCA5 And BEST1 (NASDAQ:IRD) - Seeking Alpha
Aug Patterns: Can Ameresco Inc beat the S P 500Weekly Investment Summary & Reliable Price Breakout Signals - baoquankhu1.vn
Opus Genetics (NASDAQ:IRD) Cut to "Sell" at Wall Street Zen - MarketBeat
Opus Genetics (NASDAQ:IRD) Cut to “Sell” at Wall Street Zen - Defense World
Balyasny Asset Management L.P. Acquires Significant Stake in Opu - GuruFocus
Balyasny Asset Management L.P. Acquires Significant Stake in Opus Genetics Inc - GuruFocus
Opus Genetics Closes $25 Million Series B Financing - TipRanks
Opus Genetics Raises $25 Million in Private Placement of Series B Preferred at $3.39 - TradingView
Opus Genetics (NASDAQ: IRD) boosts cash with $25M Series B preferred - Stock Titan
Aug Technicals: Can Fulgent Genetics Inc stock outperform in a bear marketQuarterly Investment Review & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
MSN Money - MSN
Opus Genetics, Inc. (NASDAQ:IRD) Given Average Rating of "Buy" by Brokerages - MarketBeat
Opus Genetics Enters Agreement for $25 Million Private Placement - VisionMonday.com
Opus Genetics Insider Confidence Rewarded, Stock Hits US$233m Market Cap - 富途牛牛
Opus Genetics higher after $25M private placement - MSN
Why Opus Genetics Inc. (R3X1) stock could rally stronglyJuly 2025 Fed Impact & Verified Stock Trade Ideas - mfd.ru
Lifesci Capital Forecasts Opus Genetics FY2025 Earnings - MarketBeat
Can Opus Genetics Inc. reach all time highs this yearWeekly Profit Summary & Weekly Return Optimization Plans - mfd.ru
Is Opus Genetics Inc. stock a good pick for beginnersJuly 2025 Chart Watch & Real-Time Volume Triggers - mfd.ru
Short Interest in Opus Genetics, Inc. (NASDAQ:IRD) Drops By 30.7% - MarketBeat
Aug Sentiment: Is FirstService Corporation stock risky to hold nowMarket Volume Summary & Weekly Watchlist of Top Performers - baoquankhu1.vn
Opus Genetics raises $25 million in private placement financing By Investing.com - Investing.com Australia
Opus Genetics (NASDAQ:IRD) Raised to Strong-Buy at Lifesci Capital - Defense World
Opus Genetics, Inc. announced that it expects to receive $25.000002 million in funding - marketscreener.com
Opus Genetics raises $25 million in private placement financing - Investing.com India
Opus Genetics announces $25 million private placement - marketscreener.com
Opus Genetics Announces $25 Million Private Placement - TradingView
3.96%
자본화:
|
볼륨(24시간):